The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice

BACKGROUND: Hypogonadism is a common complication in men with type 2 diabetes mellitus (DM), but its prevalence remains unknown. AIMS: To estimate the prevalence of hypogonadism in men with type 2 DM. MATERIALS AND METHODS: Male patients with type 2 DM were enrolled into a single-cohort contempora...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Galina A. Melnichenko, Marina V. Shestakova, Roman V. Rozhivanov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2019
Materias:	hypogonadism men testosterone deficiency testosterone diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/82acfd2bcce04ffd9b0e84cd4425bdcb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:82acfd2bcce04ffd9b0e84cd4425bdcb
record_format	dspace
spelling	oai:doaj.org-article:82acfd2bcce04ffd9b0e84cd4425bdcb2021-11-14T09:00:22ZThe prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice2072-03512072-037810.14341/DM9944https://doaj.org/article/82acfd2bcce04ffd9b0e84cd4425bdcb2019-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9944https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378BACKGROUND: Hypogonadism is a common complication in men with type 2 diabetes mellitus (DM), but its prevalence remains unknown. AIMS: To estimate the prevalence of hypogonadism in men with type 2 DM. MATERIALS AND METHODS: Male patients with type 2 DM were enrolled into a single-cohort contemporaneous multicenter non-interventional screening study. The study period was from November 2017 through August 2018. Assessments included total testosterone, luteinizing hormone (LH), sex hormone-binding globulin, HbA1c levels. Levels of free testosterone were calculated by Vermeullen method. RESULTS: TheThe median of age of 400 included men was 56 years [51; 58], total testosterone was 12.3 [9.2; 16.5] nmol/l, free testosterone – 270 [217; 334] pmol/l, HbA1c – 7,1% [6.1; 8.6]. Hypogonadism was found in 135 men (33.7%). The total testosterone level in that group was 7.9 [6.8; 9.8] nmol/l, and free testosterone – 192 [164; 227] pmol/l. In hypogonadism-free men their levels were 15,1 [12,4; 18,6] nmol/l and 311 [270; 364] pmol/l, respectively. In most patients with hypogonadism LH level was low, but within normal ranges, and significantly lower than in men without hypogonadism – 3.2 [2.1; 4.7] IU/L vs 3.8 [2.7; 4.9] IU/L, respectively (p=0.007). Most commonly hypogonadism was with normal LH levels (92,6%, median LH level 3.2 [2.2; 4.3] IU/L, p<0,001). The frequency of hypogonadism with high LH level (10.2 [9.2; 14.7] IU/L) and low LH level (1.0 [0.6; 1.1] IU/L) was 4.4% and 3.0%, respectively. CONCLUSIONS: The prevalence of hypogonadism in men with type 2 DM was found to be 33.7%. Normal levels of LH are typical for this type of patients with hypogonadism.Galina A. MelnichenkoMarina V. ShestakovaRoman V. RozhivanovEndocrinology Research Centrearticlehypogonadismmentestosterone deficiencytestosteronediabetes mellitusNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 22, Iss 2, Pp 127-130 (2019)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	hypogonadism men testosterone deficiency testosterone diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	hypogonadism men testosterone deficiency testosterone diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627 Galina A. Melnichenko Marina V. Shestakova Roman V. Rozhivanov The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
description	BACKGROUND: Hypogonadism is a common complication in men with type 2 diabetes mellitus (DM), but its prevalence remains unknown. AIMS: To estimate the prevalence of hypogonadism in men with type 2 DM. MATERIALS AND METHODS: Male patients with type 2 DM were enrolled into a single-cohort contemporaneous multicenter non-interventional screening study. The study period was from November 2017 through August 2018. Assessments included total testosterone, luteinizing hormone (LH), sex hormone-binding globulin, HbA1c levels. Levels of free testosterone were calculated by Vermeullen method. RESULTS: TheThe median of age of 400 included men was 56 years [51; 58], total testosterone was 12.3 [9.2; 16.5] nmol/l, free testosterone – 270 [217; 334] pmol/l, HbA1c – 7,1% [6.1; 8.6]. Hypogonadism was found in 135 men (33.7%). The total testosterone level in that group was 7.9 [6.8; 9.8] nmol/l, and free testosterone – 192 [164; 227] pmol/l. In hypogonadism-free men their levels were 15,1 [12,4; 18,6] nmol/l and 311 [270; 364] pmol/l, respectively. In most patients with hypogonadism LH level was low, but within normal ranges, and significantly lower than in men without hypogonadism – 3.2 [2.1; 4.7] IU/L vs 3.8 [2.7; 4.9] IU/L, respectively (p=0.007). Most commonly hypogonadism was with normal LH levels (92,6%, median LH level 3.2 [2.2; 4.3] IU/L, p<0,001). The frequency of hypogonadism with high LH level (10.2 [9.2; 14.7] IU/L) and low LH level (1.0 [0.6; 1.1] IU/L) was 4.4% and 3.0%, respectively. CONCLUSIONS: The prevalence of hypogonadism in men with type 2 DM was found to be 33.7%. Normal levels of LH are typical for this type of patients with hypogonadism.
format	article
author	Galina A. Melnichenko Marina V. Shestakova Roman V. Rozhivanov
author_facet	Galina A. Melnichenko Marina V. Shestakova Roman V. Rozhivanov
author_sort	Galina A. Melnichenko
title	The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
title_short	The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
title_full	The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
title_fullStr	The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
title_full_unstemmed	The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
title_sort	prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
publisher	Endocrinology Research Centre
publishDate	2019
url	https://doaj.org/article/82acfd2bcce04ffd9b0e84cd4425bdcb
work_keys_str_mv	AT galinaamelnichenko theprevalenceofhypogonadisminmenwithtype2diabetesmellitusinclinicalpractice AT marinavshestakova theprevalenceofhypogonadisminmenwithtype2diabetesmellitusinclinicalpractice AT romanvrozhivanov theprevalenceofhypogonadisminmenwithtype2diabetesmellitusinclinicalpractice AT galinaamelnichenko prevalenceofhypogonadisminmenwithtype2diabetesmellitusinclinicalpractice AT marinavshestakova prevalenceofhypogonadisminmenwithtype2diabetesmellitusinclinicalpractice AT romanvrozhivanov prevalenceofhypogonadisminmenwithtype2diabetesmellitusinclinicalpractice
_version_	1718429472837861376

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice

Ejemplares similares